New Delhi [India], December 28 (ANI): After reviewing all applications and data, the Subject Expert Committee (SEC), a body under India's drug regulator, has recommended granting the Emergency Use Authorization (EUA) to Serum Institute of India's COVID-19 vaccine Covovax and Corbevax vacc
New Delhi [India], December 27 (ANI): The Ministry of Health and Family Welfare on Monday issued guidelines for COVID-19 vaccination of children between 15-18 years, and precaution dose to health care and front line workers, and those above the age of 60 with comorbidities.
New Delhi [India], December 27 (ANI): Healthcare workers and those above the age of 60 and suffering from co-morbidities will be applicable for the 'precautionary dose' of coronavirus vaccines from next month only after 9 months of receiving the second dose of the COVID-19 vaccine, accord
New Delhi [India], December 27 (ANI): After reviewing all applications and data on antiviral pills, the Subject expert committee (SEC) a body under India's drug regulator will be meeting today for antiviral pill Molnupiravir recommendations, sources told to ANI.
New Delhi [India], December 26 (ANI): Covaxin has shown that it has a very good immune response in children in trials, Dr NK Arora, Chairman of Covid Task Force working group, NTAGI, said on Sunday.
New Delhi [India], December 26 (ANI): Indian Medical Association (IMA) on Saturday welcomed the decision of Prime Minister Narendra Modi to administer COVID-19 'precaution dose' to healthcare and frontline workers from January 10 next year.
New Delhi [India], December 25 (ANI): Bharat Biotech's COVID-19 vaccine Covaxin has received approval from the Drugs Controller General of India (DCGI) for emergency use for kids aged between 12-18 years, official sources said.
New Delhi [India], December 24 (ANI): The Union Health Ministry on Friday said that of the 183 Omicron positive cases reported in India, three patients have already taken three doses and 121 had a foreign travel history.
New Delhi [India], December 23 (ANI): The Lancet study, which reportedly states that the protection offered by the Oxford AstraZeneca COVID-19 vaccine Covishield declines after 3 months, has been misquoted, said experts.
New Delhi [India], December 22 (ANI): Amid the emergence of the Omicron variant of coronavirus, a Delhi-based doctor said that a booster dose of COVID vaccine is a must as the protection cover of two doses declines over three to six months.
New Delhi [India], December 22 (ANI): The requirement, timing and nature of COVID vaccine booster doses will be based on scientific decisions according to Dr VK Paul, Member-Health, Niti Aayog on Wednesday.